Pfizer’s New Breast Cancer Drug Succeeds in Trial

04/02/2014 00:26

Pfizer’s experimental breast cancer drug significantly improved patient survival rates in a mid-stage trial without their condition worsening, maintaining the company’s lead in the race for a new treatment standard for the disease. 
Reuters